Current Liabilities
Accrued Expenses
Merck & Co. Accrued Expenses increased by 2.4% to $42.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $41.00M to $42.00M. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows relatively stable performance with a -0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
How to read this metric
A steady increase relative to revenue is normal, but a sudden spike might indicate cash flow management issues or delayed payments.
Detailed definition
Accrued expenses represent obligations for goods or services that have been received but not yet invoiced or paid by the...
Peer comparison
Standard across all industries as a core component of current liabilities.
Metric ID:
accrued_expensesHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $40.00M | $39.00M | $42.00M | $41.00M | $42.00M |
| QoQ Change | — | -2.5% | +7.7% | -2.4% | +2.4% |
| YoY Change | — | -2.5% | +7.7% | -2.4% | +2.4% |
Range$39.00M – $42.00M
CAGR+5.0%
Avg YoY Growth+1.3%
Median YoY Growth+0.0%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s accrued expenses?
- Merck & Co. (MRK) reported accrued expenses of $42.00M in Q4 2025.
- How has Merck & Co.'s accrued expenses changed year-over-year?
- Merck & Co.'s accrued expenses increased by 2.4% year-over-year, from $41.00M to $42.00M.
- What is the long-term trend for Merck & Co.'s accrued expenses?
- Over 5 years (2020 to 2025), Merck & Co.'s accrued expenses has grown at a -0.5% compound annual growth rate (CAGR), from $43.00M to $42.00M.
- What does accrued expenses mean?
- Costs for services or goods the company has used but hasn't paid for yet.